Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00111644Phase 2Completed
Phase 2, randomised, double-blind trial of amoxicillin in bacterial pneumonia (3 arms), sponsored by Roche. Primary endpoint: Clinical cure rate. Started Mar 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00111644.